$ACHV
ACHIEVE LIFE SCIENCES, INC.

2020 Q1 Form 10-K Financial Statement

#000156459020010642 Filed on March 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.820M $1.450M $6.850M
YoY Change -3.7% -11.04% -1.44%
% of Gross Profit
Research & Development $1.541M $1.763M $9.674M
YoY Change -62.0% -15.28% 64.86%
% of Gross Profit
Depreciation & Amortization $60.00K $60.00K $31.00K
YoY Change -14.29% 0.0% -48.33%
% of Gross Profit
Operating Expenses $1.541M $1.763M $9.674M
YoY Change -62.0% -15.28% 64.86%
Operating Profit
YoY Change
Interest Expense $40.00K $30.00K $170.0K
YoY Change -33.33% -62.5% 0.0%
% of Operating Profit
Other Income/Expense, Net $37.00K $15.00K -$40.00K
YoY Change 2.78% -79.17% -11.11%
Pretax Income -$3.320M -$3.190M -$16.40M
YoY Change -43.73% -12.36% 29.23%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.320M -$3.194M -$16.40M
YoY Change -43.77% -12.18% 29.23%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$107.3K -$5.800M -$40.00M
COMMON SHARES
Basic Shares Outstanding 31.35M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.20M $16.70M $16.66M
YoY Change 25.77% 14.38% 14.11%
Cash & Equivalents $12.21M $16.66M $16.66M
Short-Term Investments
Other Short-Term Assets $700.0K $700.0K $660.0K
YoY Change -22.22% -22.22% -29.03%
Inventory
Prepaid Expenses $662.0K
Receivables $0.00 $8.000K $10.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.90M $17.33M $17.33M
YoY Change 22.86% 11.57% 11.52%
LONG-TERM ASSETS
Property, Plant & Equipment $300.0K $57.00K $390.0K
YoY Change -40.0% 62.86% 875.0%
Goodwill $1.034M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $300.0K $187.0K $240.0K
YoY Change 200.0% 58.47% 41.18%
Total Long-Term Assets $3.700M $3.744M $3.750M
YoY Change -7.5% 5.55% 5.93%
TOTAL ASSETS
Total Short-Term Assets $12.90M $17.33M $17.33M
Total Long-Term Assets $3.700M $3.744M $3.750M
Total Assets $16.60M $21.08M $21.08M
YoY Change 14.48% 10.45% 10.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $859.0K $860.0K
YoY Change -71.43% 496.53% 514.29%
Accrued Expenses $1.400M $2.000M $2.010M
YoY Change -57.58% -35.48% -35.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.500M $2.869M $2.870M
YoY Change -62.5% -12.26% -12.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $200.0K $160.0K
YoY Change -66.67% 1500.0%
Total Long-Term Liabilities $100.0K $200.0K $160.0K
YoY Change -66.67% 1500.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.500M $2.869M $2.870M
Total Long-Term Liabilities $100.0K $200.0K $160.0K
Total Liabilities $1.700M $3.028M $3.030M
YoY Change -60.47% -7.74% -7.62%
SHAREHOLDERS EQUITY
Retained Earnings -$49.02M -$45.70M
YoY Change 80.07%
Common Stock $64.01M $63.75M
YoY Change 54.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.99M $18.05M $18.05M
YoY Change
Total Liabilities & Shareholders Equity $16.65M $21.08M $21.08M
YoY Change 14.81% 10.45% 10.48%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$3.320M -$3.194M -$16.40M
YoY Change -43.77% -12.18% 29.23%
Depreciation, Depletion And Amortization $60.00K $60.00K $31.00K
YoY Change -14.29% 0.0% -48.33%
Cash From Operating Activities -$4.461M -$3.420M -$15.22M
YoY Change -8.75% -3.39% 43.24%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $0.00 $53.00K
YoY Change -96.3% -100.0% 15.22%
Acquisitions
YoY Change
Other Investing Activities $0.00 $5.090M
YoY Change -100.0% -200.2%
Cash From Investing Activities -$2.000K $0.00 $5.036M
YoY Change -100.07% -100.0% -198.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -47.00K 12.71M 17.33M
YoY Change 153.69% -12.31%
NET CHANGE
Cash From Operating Activities -4.461M -3.420M -15.22M
Cash From Investing Activities -2.000K 0.000 5.036M
Cash From Financing Activities -47.00K 12.71M 17.33M
Net Change In Cash -4.508M 9.290M 7.149M
YoY Change 105.38% -514.73% 78.32%
FREE CASH FLOW
Cash From Operating Activities -$4.461M -$3.420M -$15.22M
Capital Expenditures $2.000K $0.00 $53.00K
Free Cash Flow -$4.463M -$3.420M -$15.27M
YoY Change -9.71% -3.12% 43.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Liabilities
Liabilities
3028000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2869000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
159000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9515000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45704000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
63709000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
329000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
18000
CY2018Q4 us-gaap Liabilities
Liabilities
3282000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
41000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41161000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25381000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6721117
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6721117
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29485178
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
12813000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21078000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9674000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
18050000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29485178
CY2019 us-gaap Profit Loss
ProfitLoss
-16395000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5868000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6854000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6945000
CY2019 us-gaap Depreciation
Depreciation
31000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1201000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
50000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16395000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12687000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13634000
CY2017 achv Recovery Of Deferred Income Taxes
RecoveryOfDeferredIncomeTaxes
-3051000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-16395000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-12687000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-10583000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16395000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12687000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16664000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
5089000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
662000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
926000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
17334000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
15537000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
50000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
118000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
15802000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19084000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017 us-gaap Business Combination Bargain Purchase Gain Recognized Amount
BusinessCombinationBargainPurchaseGainRecognizedAmount
1272000
CY2017 achv Contingent Value Rights Recovery
ContingentValueRightsRecovery
200000
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-150000
CY2017 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-8610000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-35000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7002000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10583000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.61
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-22.07
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
479442
CY2017 achv Settlement Of Stockholder Loans With Related Parties
SettlementOfStockholderLoansWithRelatedParties
2132000
CY2017 achv Shares Issued Under Common Stock Subscription Value
SharesIssuedUnderCommonStockSubscriptionValue
64000
CY2017 achv Combined Shares Held By Equity Holders
CombinedSharesHeldByEquityHolders
3000
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
13048000
CY2017 achv Stock Issued During Period Value Restricted Stock Unit Settlements Withheld And Retired To Treasury
StockIssuedDuringPeriodValueRestrictedStockUnitSettlementsWithheldAndRetiredToTreasury
5000
CY2017 achv Purchase Accounting Adjustments
PurchaseAccountingAdjustments
44000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
7879000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.99
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8246400
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3510217
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
854000
CY2018 achv Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1324000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1201000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4000
CY2019 achv Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
4199000
CY2018 us-gaap Profit Loss
ProfitLoss
-12687000
CY2017 us-gaap Profit Loss
ProfitLoss
-10583000
CY2018 us-gaap Depreciation
Depreciation
60000
CY2017 us-gaap Depreciation
Depreciation
59000
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
223000
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
222000
CY2017 us-gaap Adjustment For Amortization
AdjustmentForAmortization
223000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
854000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
348000
CY2019 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
3000
CY2017 achv Contingent Value Rights Liability Recovery
ContingentValueRightsLiabilityRecovery
200000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-195000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
343000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1349000
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
715000
CY2018 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-69000
CY2017 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
118000
CY2019 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-328000
CY2018 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
310000
CY2017 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-2185000
CY2019 achv Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
-812000
CY2018 achv Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
322000
CY2017 achv Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
877000
CY2019 achv Increase Decrease In Employee Related Liabilities Excluding Accrued Salaries
IncreaseDecreaseInEmployeeRelatedLiabilitiesExcludingAccruedSalaries
-52000
CY2018 achv Increase Decrease In Employee Related Liabilities Excluding Accrued Salaries
IncreaseDecreaseInEmployeeRelatedLiabilitiesExcludingAccruedSalaries
710000
CY2017 achv Increase Decrease In Employee Related Liabilities Excluding Accrued Salaries
IncreaseDecreaseInEmployeeRelatedLiabilitiesExcludingAccruedSalaries
458000
CY2017 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-1028000
CY2019 achv Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-10000
CY2018 achv Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
4000
CY2017 achv Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-27000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15216000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10623000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9107000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
64000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4199000
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1324000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17325000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19757000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2001000
CY2017 achv Cash Assumed In Reverse Merger
CashAssumedInReverseMerger
12648000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000
CY2018 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
10000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
25000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5539000
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5114000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
450000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4000
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7149000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4009000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5541000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9565000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5556000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16714000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5036000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5125000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12648000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and notes thereto. Actual results could differ from these estimates. Estimates and assumptions principally relate to estimates of the fair value of our warrant liability, the initial fair value and forfeiture rates of stock options issued to employees and consultants, the estimated compensation cost on performance restricted stock unit awards, clinical trial and manufacturing accruals, estimated useful lives of property, plant, equipment and intangible assets, estimates and assumptions in contingent liabilities. </p>
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2019Q4 achv Number Of Products Approved For Commercial Sale
NumberOfProductsApprovedForCommercialSale
0
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2019 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
16700000
CY2019Q4 achv Working Capital Balance
WorkingCapitalBalance
14500000
CY2019 achv Maturity Period Of Highly Liquid Investments To Be Considered As Cash Equivalent
MaturityPeriodOfHighlyLiquidInvestmentsToBeConsideredAsCashEquivalent
P3M
CY2019 achv Description Of Maturity Period Of Financial Instruments To Be Considered As Short Term Investment
DescriptionOfMaturityPeriodOfFinancialInstrumentsToBeConsideredAsShortTermInvestment
Greater than three months and less than one year
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 achv Average Period To Maturity For Portfolio Of Cash And Marketable Securities
AveragePeriodToMaturityForPortfolioOfCashAndMarketableSecurities
P0D
CY2017Q3 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
8600000
CY2017Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P6Y
CY2015Q2 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
3100000
CY2015Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P14Y
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
223000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
223000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
223000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
223000
CY2019Q4 achv Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1195000
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2019Q4 us-gaap Cash
Cash
949000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2018Q4 us-gaap Cash
Cash
1070000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2019 achv Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2019 achv Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
657000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
600000
CY2019 achv Period Of Not Utilizing Deferred Share Issuance Costs And Prepaid Amounts Related To Insurance
PeriodOfNotUtilizingDeferredShareIssuanceCostsAndPrepaidAmountsRelatedToInsurance
P12M
CY2019 achv Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.21
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1753000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1628000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
3014000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
2796000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
3294000
CY2018 achv Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.21
CY2017 achv Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3490000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2664000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4636000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
116000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
70000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-174000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-13000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-1416000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
3158000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-296000
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-165000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
314000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
84000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3246000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4182000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1683000
CY2019 achv Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
-75000
CY2018 achv Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
20000
CY2019 achv Income Tax Reconciliation Unrecognized Tax Benefits
IncomeTaxReconciliationUnrecognizedTaxBenefits
7192000
CY2019 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-221000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-104000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-27000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-14000
CY2019 achv Income Tax Expense Benefit Excluding Adjustment For Reversal Of Deferred Tax Liability
IncomeTaxExpenseBenefitExcludingAdjustmentForReversalOfDeferredTaxLiability
-221000
CY2017 achv Income Tax Expense Benefit Excluding Adjustment For Reversal Of Deferred Tax Liability
IncomeTaxExpenseBenefitExcludingAdjustmentForReversalOfDeferredTaxLiability
-3035000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
25300000
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
17600000
CY2019 achv Unclaimed Tax Deductions Related To Scientific Research And Experimental Development Expenditures
UnclaimedTaxDeductionsRelatedToScientificResearchAndExperimentalDevelopmentExpenditures
15500000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
891000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
886000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33166000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
37332000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6256000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5707000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
315000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
171000
CY2019Q4 achv Deferred Tax Assets Capitalized Research And Development Expenses
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses
3501000
CY2018Q4 achv Deferred Tax Assets Capitalized Research And Development Expenses
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses
3334000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
79000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
181000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
170000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44389000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47600000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43875000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47123000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
514000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
477000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
474000
CY2019Q4 achv Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
79000
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
435000
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
3000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
514000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
477000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
717000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
715000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
715000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
7000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
6000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
4000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
724000
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
700000
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 achv Class Of Warrant Or Right Exercise Period
ClassOfWarrantOrRightExercisePeriod
P5Y
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.00
CY2019 achv Class Of Warrant Or Right Cancellation Description
ClassOfWarrantOrRightCancellationDescription
Additionally, subject to certain exceptions, if, after the June 19, 2018, (i) the volume weighted average price of our common stock for each of 30 consecutive trading days, or the 2018 Measurement Period, which 2018 Measurement Period commences on June 19, 2018, exceeds 300% of the exercise price (subject to adjustments for stock splits, recapitalizations, stock dividends and similar transactions), (ii) the average daily trading volume for such 2018 Measurement Period exceeds $500,000 per trading day and (iii) certain other equity conditions are met, and subject to a beneficial ownership limitation, then we may call for cancellation of all or any portion of the warrants then outstanding.
CY2018Q2 achv Number Of Required Consecutive Days Weighted Average Trading Price For Cancelation Or Recall Of Warrants
NumberOfRequiredConsecutiveDaysWeightedAverageTradingPriceForCancelationOrRecallOfWarrants
P30D
CY2018Q2 achv Minimum Required Trading Price Percentage Over Exercise Price For Cancelation Or Recall Of Warrants
MinimumRequiredTradingPricePercentageOverExercisePriceForCancelationOrRecallOfWarrants
3.00
CY2018Q2 achv Minimum Required Trading Volume Value Per Day For Cancelation Or Recall Of Warrants
MinimumRequiredTradingVolumeValuePerDayForCancelationOrRecallOfWarrants
500000
CY2019 achv Gross Proceeds From Sale Of Warrants And Units
GrossProceedsFromSaleOfWarrantsAndUnits
13800000
CY2019 achv Warrant And Units Offering Cost Including Underwriting Discounts And Commissions
WarrantAndUnitsOfferingCostIncludingUnderwritingDiscountsAndCommissions
1600000
CY2019 achv Net Proceeds From Sale Of Warrants And Units
NetProceedsFromSaleOfWarrantsAndUnits
12200000
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
5134
CY2018 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
5354
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0252
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0293
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M19D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M4D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9425
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8823
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.33
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
665585
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
345350
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
352
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1010583
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.65
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.73
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2450.80
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.05
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1010583
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
10.05
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y8M8D
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1763000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1885000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1630000
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
325379
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
22.93
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P8Y5M4D
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1800000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2400000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
900000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1000000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0.6
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2017 achv Number Of Warrants Exercised
NumberOfWarrantsExercised
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28100000
CY2019Q4 us-gaap Contractual Obligation
ContractualObligation
377000
CY2019Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
213000
CY2019Q4 us-gaap Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
158000
CY2019Q4 us-gaap Contractual Obligation Due In Fourth And Fifth Year
ContractualObligationDueInFourthAndFifthYear
6000
CY2019 achv Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2019-01
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
176000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
455000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M28D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0997
CY2019Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2019 achv Indemnification Expense
IndemnificationExpense
0
CY2017Q3 achv Number Of Terminated Senior Executives
NumberOfTerminatedSeniorExecutives
1
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4055000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2032000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1824000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1893000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1446000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
5940000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
3662000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
3717000
CY2019Q4 us-gaap Costs And Expenses
CostsAndExpenses
3209000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
38000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
44000
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5904000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3624000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-3673000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-3194000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1201000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1045000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1541000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2081000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1813000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1751000
CY2018Q4 us-gaap Costs And Expenses
CostsAndExpenses
3709000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
54000
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
72000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-3022000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-2788000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3240000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-3637000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.43
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.82
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55

Files In Submission

Name View Source Status
0001564590-20-010642-index-headers.html Edgar Link pending
0001564590-20-010642-index.html Edgar Link pending
0001564590-20-010642.txt Edgar Link pending
0001564590-20-010642-xbrl.zip Edgar Link pending
achv-10k_20191231.htm Edgar Link pending
achv-20191231.xml Edgar Link completed
achv-20191231.xsd Edgar Link pending
achv-20191231_cal.xml Edgar Link unprocessable
achv-20191231_def.xml Edgar Link unprocessable
achv-20191231_lab.xml Edgar Link unprocessable
achv-20191231_pre.xml Edgar Link unprocessable
achv-ex1027_925.htm Edgar Link pending
achv-ex211_12.htm Edgar Link pending
achv-ex231_11.htm Edgar Link pending
achv-ex311_8.htm Edgar Link pending
achv-ex312_10.htm Edgar Link pending
achv-ex321_6.htm Edgar Link pending
achv-ex322_9.htm Edgar Link pending
achv-ex412_639.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending